| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/12/2010 | US7645869 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 01/12/2010 | US7645446 Glutamic acid decarboxylase (GAD) based delivery system |
| 01/12/2010 | US7645441 Compositions and methods in cancer associated with altered expression of PRLR |
| 01/12/2010 | CA2409995C Online media exchange |
| 01/12/2010 | CA2407298C Mixtures of triblock polyesterpolyethylene glycol copolymers |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/07/2010 | WO2010002940A2 Heterogeneous synthesis of multivalent chimeric immunomodulatory compounds using platform based molecules |
| 01/07/2010 | WO2010002465A2 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/07/2010 | WO2010002418A2 Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001909A1 Double-stranded polynucleotide |
| 01/07/2010 | WO2010000849A2 A method for the screening of conserved secreted proteins |
| 01/07/2010 | WO2010000072A1 Method of treating hearing loss using xiap |
| 01/07/2010 | WO2009126805A3 Therapeutic tarageting of mmps in neutral liposomes |
| 01/07/2010 | WO2009117656A3 Capsid-incorporated antigen for novel adenovirus vaccine |
| 01/07/2010 | US20100004436 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004435 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004434 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004323 Promoter construct |
| 01/07/2010 | US20100004318 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004317 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004316 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 01/07/2010 | US20100004313 Modified Poloxamers for Gene Expression and Associated Methods |
| 01/07/2010 | US20100004142 siRNA targeting myeloid cell Leukemia sequence 1 |
| 01/07/2010 | US20100003758 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100003719 Trimerising Module |
| 01/07/2010 | US20100003673 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 01/07/2010 | US20100003672 Cdna for human methylenetetrahydrofolate reductase and uses thereof |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003268 Therapy of Malignant Neoplasias |
| 01/07/2010 | US20100003264 Reduction of Ophthalmalogic Neovascularization |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003241 Agents for treatment or prevention of an allergic disorder |
| 01/07/2010 | US20100003219 Methods to Increase Transgene Expression From Bacterial-Based Delivery Systems by Co-Expressing Suppressors of the Eukaryotic Type I Interferon Response |
| 01/07/2010 | US20100003195 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729757A1 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/07/2010 | CA2728877A1 Method of treating hearing loss using xiap |
| 01/06/2010 | EP2141231A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR |
| 01/06/2010 | EP2141173A1 Methods and compositions for the inhibition of gene expression |
| 01/06/2010 | EP2140876A1 Therapeutic agent comprising vasohibin |
| 01/06/2010 | EP2140870A1 Prompt nucleic acid delivery carrier composition |
| 01/06/2010 | EP2140004A2 Genetic suppression and replacement |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1432722B1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/06/2010 | EP1289368B1 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | CN101618049A Treatment of neoplasms with viruses |
| 01/06/2010 | CN100578227C TTK in diagnosis and as a therapeutic target in cancer |
| 01/06/2010 | CN100577680C Inhibition of SyK kinase expression |
| 01/06/2010 | CN100577212C Function of E4BP4 gene in embryo implantation course and application thereof |
| 01/06/2010 | CN100577203C Use of urease for inhibiting cancer cell growth |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642349 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 01/05/2010 | US7642343 Micelles; complexes; stability; MALDI-TOF-MS |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642071 Expressing Gram-negative glycosaminoglycan synthase gene in a Gram-positive bacterial host background to produce GAGs by fermentation in vivo; providing a purified nucleic acid segment encoding an enzymatically active chondroitin synthase |
| 01/05/2010 | US7642044 Trimerising module |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641897 Feeder layer and serum independent embryonic stem cells |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2369884C Transiently immortalized cells for use in gene therapy |
| 01/05/2010 | CA2358948C Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 01/05/2010 | CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326054 Compositions and methods for inhibiting translation of a mect1-maml2 chimeric gene |
| 12/31/2009 | US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same |
| 12/31/2009 | US20090326051 Modulation of gene expression through endogenous small RNA targeting of gene promoters |
| 12/31/2009 | US20090326048 Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes |
| 12/31/2009 | US20090326047 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/31/2009 | US20090326046 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/31/2009 | US20090326045 Compositions and methods for topical delivery of oligonucleotides |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325859 Citric acid polymers |
| 12/31/2009 | US20090325286 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/31/2009 | US20090325285 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/31/2009 | US20090325181 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 12/31/2009 | US20090325180 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324591 Treatment of pulmonary disease conditions |
| 12/31/2009 | US20090324546 Method for modulating gene expression by modifying the cpg content |
| 12/31/2009 | US20090324507 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions |
| 12/30/2009 | WO2009158563A1 Method for treating or preventing radiation damage by in vivo gene therapy |
| 12/30/2009 | WO2009158284A2 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 12/30/2009 | WO2009158040A2 Cancer platinum resistance detection and sensitization method |
| 12/30/2009 | WO2009157602A1 The recombinant chimeric protein for the diagnosis of taenia solium infection and diagnostic kits comprising the same toward a standardized serodiagnosis of taenia solium neurocysticercosis |
| 12/30/2009 | WO2009155669A1 Method of treatment of vascular complications |
| 12/30/2009 | WO2009155662A1 A tumour suppressor protein, caspase-2 |
| 12/30/2009 | WO2009120380A3 Recombinant rhinovirus vectors |
| 12/30/2009 | WO2009105260A3 Ultra-small rnas as toll-like receptor-3 antagonists |
| 12/30/2009 | WO2009064920A3 Compounds and methods for modulating protein expression |
| 12/30/2009 | WO2009064917A3 Generation of an hla-negative osteogenic precursor cell line |
| 12/30/2009 | WO2009062104A3 Aberrant expression of zinc transporter zip4 (slc39a4) significantly contributes to human pancreatic cancer pathogenesis and progression |